Hybrigenics Services
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Other R&D services
Hybrigenics Services is a global leader in protein interaction discovery, with 25+ years of expertise and 600+ customer publications. We offer advanced platforms for molecular glue screening, target identification, and synthetic nanobody discovery.
Our Y2HChem platform identifies protein-protein interactions induced or stabilized by small molecules, using 135+ proprietary libraries or our unique human E3 ligase cDNA library (600+) to discover substrate–E3 interactions.
The YchemH system is our yeast three-hybrid (Y3H) platform for identifying small molecule targets—ideal for pinpointing on- and off-targets.
We also offer a cyclic peptide library (14 million clones, 4–6 amino acids) generated with SICLOPPS technology for discovering novel intracellular modulators.
Our synthetic nanobody platform uses phage display to generate high-affinity, target-specific binders.
Hybrigenics is a trusted partner, delivering reliable, high-quality results that accelerate scientific discovery.